NASDAQ: SLNO - Soleno Therapeutics, Inc.

六个月盈利: +12.81%
股息率: 0.00%
部门: Healthcare

促销时间表 Soleno Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2014-11-13
ISIN US8342033094
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://soleno.life
Цена ао 54.92
每日价格变化: -4.77% (47.065)
每周价格变化: -0.7968% (45.18)
每月价格变化: -19.73% (55.84)
3个月内价格变化: -8.77% (49.13)
六个月内的价格变化: +12.81% (39.73)
每年价格变化: +11.35% (40.25)
3年内价格变化: +8 246.37% (0.537)
5年内价格变化: +2 810.39% (1.54)
10年价格变化: 0% (44.82)
年初以来价格变化: -20.38% (56.29)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 3.97 4
P/E 0 0
EV/EBITDA -12.41 0
全部的: 2.25

效率

姓名 意义 年级
ROA, % -21.58 0
ROE, % -24.75 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.011 10
全部的: 8.2

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -51866.73 0
盈利能力 Ebitda, % 132.89 10
盈利能力 EPS, % -85.02 0
全部的: 3.6
更多详情

机构 体积 分享, %
Vivo Capital, LLC 8418093 25.93
Nantahala Capital Management, LLC 5712702 17.6
Perceptive Advisors LLC 3074542 9.47
Carlyle Group Inc. 2857804 8.8
Janus Henderson Group PLC 2523897 7.78
Adage Capital Partners GP L.L.C. 1826814 5.63
Vestal Point Capital, LP 1300000 4
Vanguard Group Inc 969622 2.99
Balyasny Asset Management LLC 926876 2.86
Avoro Capital Advisors LLC 785000 2.42

ETF 分享, % 本年盈利能力, % 股息, %
iShares Russell 2000 Growth ETF 0.08818 38.04 0.6026
iShares ESG Aware MSCI USA Small-Cap ETF 0.04862 18.09 1.49366
iShares Morningstar Small-Cap Growth ETF 0.04077 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.04077 33.63 0.72598
iShares Morningstar Small-Cap ETF 0.02055 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.02055 30.1 1.60498
iShares Russell 3000 ETF 0.00204 24.83 1.43482



导师 职称 支付 出生年份
Dr. Anish Bhatnagar M.D. President, CEO, COO & Director 1.06M 1970 (55 年)
Mr. James H. MacKaness Chief Financial Officer 640k 1964 (61 年)
Dr. Neil M. Cowen M.B.A., Ph.D. Senior Vice President of Drug Development N/A
Ms. Kristen Yen M.S. Senior Vice President of Clinical Operations 317.19k 1969 (56 年)
Ms. Meredith Manning M.B.A. Chief Commercial Officer N/A 1972 (53 年)
Ms. Patricia C. Hirano M.P.H. Senior Vice President of Regulatory Affairs 493k 1966 (59 年)
Ms. Lauren Budesheim Vice President of People N/A
Dr. Michael Huang M.D. Senior Vice President of Clinical Development N/A 1974 (51 年)
Dr. Raymond W. Urbanski M.D., Ph.D. Chief Development Officer 1959 (66 年)

地址: United States, Redwood City. CA, 203 Redwood Shores Parkway - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://soleno.life